Articles by James Calloway
Karman Shares Surge Then Slide as Earnings Confirm High Expectations
Karman Holdings shares surged 6.2% then tumbled 11% after hours as Q1 earnings met estimates but high expectations and contingent orders raised caution.
Velo3D Surges 25% on Q1 Beat, Margin Improvement
Velo3D shares surged 24.7% in after-hours trading after Q1 revenue rose 48% to $13.8 million and gross margin improved to 17.2%. The company maintains its positive EBITDA guidance for late 2026.
Nextpower Surges After Q4 Beat, Raised Guidance Boosts Platform Narrative
Nextpower shares surged 10% after hours following Q4 results that topped estimates and a raised fiscal 2027 revenue outlook, fueling investor confidence in its platform expansion.
United Flight Attendants Ratify Deal with 31% Pay Hike and Boarding Compensation
United Airlines flight attendants ratified a five-year contract with a 31% base-pay increase, boarding pay, and $741 million in retroactive wages, ending a lengthy negotiation.
Oklo Shares Slide as Q1 Loss Triples, Cash Hoard Tops $2.5 Billion
Oklo reported a Q1 net loss of $33.1 million, more than triple last year, as R&D and admin costs surged. The company holds $2.54 billion in cash but has no reactor revenue.
BAT Shares Surge on FDA Policy Shift and Legal Resolution
British American Tobacco shares rose 5.82% in London after the FDA signaled a softer stance on e-cigarette enforcement and a U.S. judge dismissed a North Korea sanctions case.
Oscar Health Shares Surge as Focus Shifts to Margin Strength
Oscar Health shares rose 7.9% to $23.73 late Tuesday as investors prioritized strong profit margins over a Q1 revenue miss, with the medical loss ratio improving to 70.5%.
Zebra Technologies Surges on Strong Q1 Results and Upgraded Forecast
Shares of Zebra Technologies climbed 11.5% after Q1 earnings beat estimates and the company raised its full-year guidance, pointing to a rebound in automation demand.
UnitedHealth Shares Surge as Investors Bet on Recovery, PBM Reform
UnitedHealth shares climbed 3.1% as the company unveiled a new Optum Rx fee-based pricing model and raised 2026 profit guidance, signaling a potential turnaround.
ZoomInfo Plunges 35% on AI Disruption, Cuts 2026 Revenue Forecast
ZoomInfo shares tumbled 35% Tuesday after the company slashed its 2026 revenue forecast to $1.185-1.205 billion, citing AI-related buying pauses and pricing pressure.
Broadwind Soars 70% as Power-Demand Narrative Overhauls Wind-Tower Exit
Broadwind stock surged ~70% to $3.46 after a smaller-than-expected Q1 loss and revenue beat. Orders jumped 23%, driven by power-generation and natural-gas turbine demand, as the company exits wind-tower production.